Our sectors

We treat all personal data in accordance with our privacy policy.
Show Site Navigation

Shipbreaker receives substantial compensation from former employers following mesothelioma diagnosis

A man who was heavily exposed to asbestos while working as a shipbreaker has received substantial compensation after being diagnosed with asbestos-related cancer

Dockside ship

17 March 2017

A 66-year-old man who was heavily exposed to asbestos while working as a shipbreaker from the mid 1960s up until the 1990s has received substantial compensation after being diagnosed with the asbestos-related cancer, mesothelioma.

Despite clear evidence that several of his former employers had failed to adequately protect him from inhaling deadly asbestos dust and fibres, during a period when the dangers were well known, it was not until court proceedings were issued that it was admitted that they were legally blameworthy.
Before the onset of his symptoms, our client had a very full life. He is a devoted family man, and his main concern in bringing a claim for compensation was to provide for his wife financially, and to ensure that her care needs continue to be met.

In a bid to extend his life, and to remain fit and active for as long as possible, he underwent radical surgery, followed by chemotherapy treatment.

His settlement monies included an amount claimed in respect of the cost of immunotherapy treatment, which has shown some promising results in a small number of mesothelioma patients, and which is not currently available on the NHS.
Specialist asbestos disease solicitor, Sarah Wolf, said:
“Mesothelioma is a devastating illness, not only for the sufferers, but also for their families, who have to witness the deterioration in their health and live with the knowledge that the condition will probably shorten their lives.
“I am very pleased that this claim has now been successfully settled, and hope this has brought some peace of mind to a very courageous man and his family.”

Information was correct at time of publishing. See terms and conditions for further details.

Share this page: Print this page

Contact us

    More information